The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics

D. Pinot, A. Nieves, A. M. Lorec, D. P. Breen, M. Badier, D. Vervloet, A. Magnan (Marseille, France)

Source: Annual Congress 2007 - Towards controlling severe asthma
Session: Towards controlling severe asthma
Session type: Oral Presentation
Number: 1588
Disease area: Airway diseases

Congress or journal article abstractSlide presentationMultimedia filesE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Pinot, A. Nieves, A. M. Lorec, D. P. Breen, M. Badier, D. Vervloet, A. Magnan (Marseille, France). The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics. Eur Respir J 2007; 30: Suppl. 51, 1588

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Eosinophilic inflammation in sputum of poorly controlled asthmatics
Source: Eur Respir J 2002; 20: 1370-1377
Year: 2002

Inflammatory subtypes in cough variant asthma (CVA): assessment using induced sputum
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007

Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006

Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production.
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011

Current control, airway inflammation, and subsequent exacerbation in patients with asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010

The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020

Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005

The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics
Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity
Year: 2008

Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age
Source: Eur Respir J 2005; 26: Suppl. 49, 48s
Year: 2005

Severe exacerbations predict excess lung function decline in asthma
Source: Eur Respir J 2007; 30: 452-456
Year: 2007

Problematic severe asthma
Source: Eur Respir Mon 2012; 56: 22-39
Year: 2012

Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma
Source: Eur Respir J 2002; 19: 846-852
Year: 2002

Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005

Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001

Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007

Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021